drugset / Trial / NCT00457353

ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children

NCT00457353

Phase 3 Completed 264 enrolled Sanofi
RandomizedParallel-groupOpen-labelTreatment

Summary

Primary: * To demonstrate the efficacy of Enterogermina® in reducing the duration of acute diarrhea in children Secondary: * To evaluate the safety of Enterogermina® in acute diarrhea in Indian children

Timeline

Start
2007-03
Primary completion
2007-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bacillus clausii Other / unclassified 2e+09 unknown Oral

Indications